RxDoctor Payments Data

Susan Metcalf

Nurse Practitioner · Kissimmee, FLNPI 1598979700

Payments from drug & device makers

$4,285in general payments, 2019–2025

Across 150 payments — averaging $28.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$1K
  • Sanofi$453
  • Philips North America LLC$402
  • Boehringer Ingelheim$352
  • Actelion Pharmaceuticals US, Inc.$280
  • Takeda Pharmaceuticals U.S.A., Inc.$230
  • plus $1K from 19 others

What the payments were for

  • Consulting fees$43810%
  • Food & beverage$3,75288%
  • Education$952%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,285 in reported general payments places this provider in the 90th percentile of 8,290 nurse practitioner providers in Florida.

See all nurse practitioner providers in Florida

Most prescribed under Part D

DrugClaimsCost to plans & patients
Trelegy ElliptaFluticasone/Umeclidin/Vilanter33$33,869
Breztri AerosphereBudesonide/Glycopyr/Formoterol26$26,953
OzempicSemaglutide19$17,625
Spiriva RespimatTiotropium Bromide13$13,496
Breo ElliptaFluticasone/Vilanterol18$10,592
SymbicortBudesonide/Formoterol Fumarate11$3,909
Albuterol Sulfate HfaAlbuterol Sulfate31$1,282
Montelukast Sodium49$780

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
GSKTrelegy Ellipta, Breo Ellipta$119$44,46051 claims
AstraZenecaBreztri Aerosphere, Symbicort$1,206$30,86237 claims
Boehringer IngelheimSpiriva Respimat$352$13,49613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 8,290 nurse practitioner providers in Florida.

Other nurse practitioner in Kissimmee

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →